Menu

Search

Renee Ragin Randall

Renee Ragin Randall

Assistant Professor of Comparative Literature and Middle East Studies, University of Michigan
I am a scholar of war and trauma; world literature and literary culture; visual studies; and the Global South. My current book project is on moral, social and ideological collapse during the Lebanese civil wars (1975-1990) as represented by the recurrent trope of madness in literature and visual arts produced during and after the conflict. Prior to my return to academia, I served as a Foreign Service Officer with the US Department of State in Washington DC and Saudi Arabia. I am also on the board of a local chapter of the National Alliance on Mental Illness (NAMI).

1 

Economy

Dollar Stabilizes Amid Trade War Easing Hopes and Yen Waits on BOJ Decision

The U.S. dollar held steady on Thursday, shrugging off weak domestic data as markets turned hopeful over signs of easing global trade tensions. Despite suffering its steepest monthly decline in over two years through...

US Stock Futures Surge as Microsoft and Meta Earnings Beat Forecasts

U.S. stock futures rose sharply Wednesday night, driven by strong earnings reports from tech giants Microsoft and Meta Platforms. This positive momentum came after a choppy regular session where Wall Street posted modest...

Asian Stocks Mixed as China, Japan Factory Data Disappoint; India, Korea Decline on Geopolitical Risks

Asian stock markets were mostly flat on Wednesday as investors weighed weak factory activity data from China and Japan, alongside Australian inflation figures and heightened regional tensions. Chinas official manufacturing...

Oil Prices Dip Amid Tariff Concerns, Rising Inventories, and OPEC+ Output Worries

Oil prices slipped in early Asian trading Wednesday, pressured by renewed concerns over global economic growth and fuel demand due to U.S. tariff policies and rising crude inventories. Brent crude futures fell 17 cents, or...

U.S. Stock Futures Dip as Investors Monitor Trade Developments, Earnings, and Key Data

U.S. stock futures slipped Tuesday evening as investors digested signs of easing trade tensions, soft economic data, and awaited major corporate earnings. SP 500 futures fell 0.2% to 5,571.75, while Nasdaq 100 futures...

Politics

Trump Hints at Trade Deals with India, South Korea, and Japan

U.S. President Donald Trump stated on Wednesday that potential trade agreements with India, South Korea, and Japan are in the works, as he looks to transform his tariff strategy into formal trade pacts. Speaking during a...

U.S. Approves $425M Patriot Missile System Sale to Kuwait

The U.S. State Department has cleared a potential $425 million sale of Patriot missile system equipment and support services to Kuwait, a move aimed at bolstering defense ties between the two nations. The announcement was...

US-Ukraine Investment Deal Boosts Reconstruction, Sends Warning to Russia

The United States and Ukraine have signed a new economic partnership to accelerate Ukraines reconstruction and secure U.S. access to the countrys natural resources. The agreement, reached on April 30, establishes the...

No U.S.-China Trade Talks Yet, Says Trade Representative Greer

U.S. Trade Representative Jamieson Greer confirmed there are no official trade talks currently underway with China, despite President Donald Trumps earlier claims of ongoing negotiations. Speaking to Fox News on Wednesday,...

Trump Touts Economic Record, Promises Tax Cuts at Michigan Rally Amid Recession Fears

President Donald Trump rallied supporters in Warren, Michigan, marking his first 100 days in office with bold claims about the U.S. economy, promises of sweeping tax cuts, and sharp criticism of Democrats. Speaking near...

Science

Kennedy Sets September Deadline to Uncover Autism Causes Amid Controversy

U.S. Health and Human Services Secretary Robert F. Kennedy Jr. announced a bold plan to identify the cause of autism by September 2025. Speaking at a cabinet meeting with President Donald Trump, Kennedy declared a global...

AstraZeneca’s Imfinzi Gets US Approval for Bladder Cancer Treatment

AstraZenecas drug Imfinzi (NASDAQ: AZN) has received U.S. approval to treat adult patients with muscle-invasive bladder cancer, a significant advancement in cancer therapy. The approval allows Imfinzi to be used in...

Sanofi’s New Hemophilia Drug Qfitlia Gains FDA Approval with Breakthrough Bimonthly Dosing

The U.S. Food and Drug Administration (FDA) has approved Qfitlia, a groundbreaking hemophilia treatment by French pharmaceutical giant Sanofi (NASDAQ: SNY). Designed for patients aged 12 and older with hemophilia A or B,...

FDA Vaccine Chief Peter Marks Resigns Amid Controversy Over Transparency

Peter Marks, the U.S. Food and Drug Administrations (FDA) top vaccine official, has resigned after reportedly being forced out by the Department of Health and Human Services (HHS), according to The Wall Street Journal....

Museums have tons of data, and AI could make it more accessible − but standardizing and organizing it across fields won’t be easy

Ice cores in freezers, dinosaurs on display, fish in jars, birds in boxes, human remains and ancient artifacts from long gone civilizations that few people ever see museum collections are filled with all this and more....

Technology

Xiaomi Unveils MiMo AI Model, Shares Surge 5% on Breakthrough Launch

Xiaomi Corp (HK:1810) launched its first open-source large language model, MiMo, on Wednesday, marking its official entry into the competitive artificial intelligence space. The debut sent Xiaomis Hong Kong-listed shares...

Alibaba Launches Qwen 3 AI Model Amid Intensifying China Tech Competition

Chinese tech giant Alibaba Group (NYSE:BABA) unveiled Qwen 3 on Tuesday, a next-generation AI model featuring hybrid reasoning capabilities aimed at boosting performance and adaptability. The move underscores Alibabas...

Amazon Enters Satellite Internet Race with First Kuiper Deployment

Amazon (NASDAQ:AMZN) has officially entered the satellite broadband market with the successful launch of 27 operational satellites for Project Kuiper, its high-speed internet initiative aimed at rivaling SpaceXs Starlink....

Chinese AI App DeepSeek Resumes Downloads in South Korea After Privacy Update

Chinese artificial intelligence app DeepSeek has resumed availability in South Koreas app stores after a two-month suspension due to data protection concerns. Downloads were halted in February when South Koreas Personal...

Nvidia Shares Dip as Huawei Tests Rival AI Chip

Nvidia Corporation (NASDAQ: NVDA) slipped in after-hours trading on Sunday, following reports that Chinas Huawei is testing a powerful artificial intelligence chip aimed at challenging Nvidias dominance. NVDA shares fell...
  • Market Data
Close

Welcome to EconoTimes

Sign up for daily updates for the most important
stories unfolding in the global economy.